Benzinga's Top Upgrades
Analysts at CLSA upgraded Allergan (NYSE: AGN) from “underperform” to “outperform.” Allergan's shares closed at $91.50 on Friday. Allergan's trailing-twelve-month revenue is $5.61 billion.
Analysts at UBS upgraded Questar (NYSE: STR) from “neutral” to “buy.” Questar's stock closed at $19.37 on Friday. Questar's trailing-twelve-month operating margin is 33.27%.
Analysts at Goldman upgraded Rubicon Technology (NASDAQ: RBCN) from “sell” to “neutral.” Rubicon Technology's shares closed at $10.31 on Friday. Rubicon Technology's PEG ratio is -3.25.
Analysts at Deutsche Bank upgraded Cooper Tire & Rubber (NYSE: CTB) from “hold” to “buy.” Cooper Tire & Rubber's shares closed at $19.94 on Friday. Cooper Tire & Rubber's trailing-twelve-month operating margin is 6.03%.
Latest Ratings for AGN
|Dec 2014||Goldman Sachs||Downgrades||Buy||Hold|
|Dec 2014||Stifel Nicolaus||Downgrades||Buy||Hold|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.